New treatment for relapsing malaria, tafenoquine rolled out in Brazil starting with the Yanomami indigenous people 25 Mar 2024
Real-world effectiveness of single-dose tafenoquine for P. vivax relapse prevention confirmed in retrospective observational study in Brazil 05 Mar 2024
The Lancet Global Health publishes groundbreaking results from the Tafenoquine Roll-out STudy (TRuST) in the Brazilian Amazon 14 Feb 2024
Brazil becomes the first malaria-endemic country to register single-dose tafenoquine for children with relapsing malaria 21 Aug 2023
WHO call for public consultation on preferred product characteristics (PPCs) on tests for risk of P. vivax relapse 10 Aug 2023
Brazil becomes the first malaria-endemic country to adopt single-dose tafenoquine and STANDARD G6PD Test for the treatment of relapsing Plasmodium vivax malaria 06 Jun 2023
MMV’s film on real-world tafenoquine study wins advocacy award at the 7th annual ISNTD festival 28 Mar 2023
Regional initiatives and evidence-generation efforts to eliminate P. vivax malaria in Latin America 05 Dec 2022
Start of ARCTIC, a feasibility study of a new Plasmodium vivax malaria treatment protocol in Thailand 22 Jul 2022
29 May 2024 2024 Geneva Health Forum This year's GHF will focus on health and the environment with a day dedicated to the elimination of malaria. 27 - 29 May 2024 Geneva, Switzerland
12 Feb 2025 9th International Conference on Plasmodium vivax Research (ICPvR) 2025 The 9th International Conference on Plasmodium vivaxResearch will take place in Puducherry, India from 12th to 14th February 2025. 12 - 14 Feb 2025 Puducherry, India